NeoSoul Review 2026: DNA Token, NeoTrade and Risks

What NeoSoul builds: NeoTrade and evoevo

NeoSoul calls its field the agent economy: AI agents that do paid economic work under human authorization. The project starts with trading, because markets score every decision.

NeoTrade is a local-first desktop app for macOS and Windows. A user picks a strategy, sets position and order caps, and chooses one of two modes:

• Copilot. The agent proposes each trade and the user approves it.
• Auto. The agent trades on its own inside the set limits.

Each agent gets its own wallet, strategy and venue. A global "STOP ALL" switch halts every agent at once. Private keys are generated and encrypted on the device, and NeoTrade does not custody assets (IQ.wiki).

Three venues are live:

1. Paper, with live market data and simulated funds
2. predict.fun, with real money
3. Polymarket, with real money

Crypto exchanges and US equities are on the roadmap. A Skill Builder lets users describe a strategy in a conversation, and the system turns it into parameters.

The second product, evoevo, is a training ground. Agents publish reasoning on sports, crypto, macro and current events, users calibrate it, and real outcomes score it. Agents hold persistent NFT identities on-chain.

What NeoSoul has not published matters as much. No user count, no number of active agents, no aggregate performance record and no fee schedule.

Team, funding and backers

NeoSoul presents itself as a Singapore team. Dealroom lists Kuala Lumpur and a valuation range of $25M-$50M. ChainCatcher quotes a co-founder named Kaelan. We found no full team page with names and backgrounds.

The money side is clearer. In August 2026 NeoSoul announced an $11M Pre-A round led by MH Ventures, with these participants (IQ.wiki):

• Amber Group
• ArkStream Capital
• 0G Foundation
• Kirin Capital, which also backs expansion in Vietnam and Southeast Asia
• CatcherVC
• New Oak International

IQ.wiki also lists 13 partners, from BNB Chain and 0G Labs to Microsoft Azure, Google Cloud and MetaMask. Seven of the 13 are cloud, wallet or node providers, and two (Galxe, TaskOn) are campaign platforms. A cloud account is not a partnership in the commercial sense.

DNA token: supply, unlocks and the Believe Plan

DNA has a fixed supply of 1 billion. The contract has no mint function, no owner role and no upgradeable proxy, according to Phemex's on-chain review. That rules out a fresh mint as a supply surprise.

Allocation per the official documents (Bittime):

The documents put circulation at 130M at launch and 355M after one year. CoinMarketCap and CryptoSlate show 90M. The 40M gap matches the liquidity allocation, and no source explains it.

On launch day NeoSoul announced the Believe Plan. Its terms:

• Team tokens keep the 12-month lock, but linear vesting is replaced by unlocks tied to KPIs set with the community. A missed KPI means no unlock for that period.
• Investor schedules stay unchanged. Shareholders who extend their lock receive token rewards.
• Staff choose whether to take a larger share of salary in DNA, bought on the open market with no lock-up.
• NeoTrade is to accept only DNA for Agents, Skills and data services. Technical partners paying in DNA get a 20% discount.

The plan is unusual, and it hinges on one document. The KPI framework was due for publication after day one. We found no published version as of 4 November 2026.

How the launch traded

DNA opened on Binance Alpha on 16 October 2026, with KuCoin, MEXC, Bitget, Gate and OKX announced the same day. Binance Alpha is an early-stage section, not a Binance spot listing.

The first day ran hot. The main PancakeSwap pool opened at $0.07431 and closed at $0.2879, up 287%, on $47.81M of volume (Phemex). More than half of that gain came in the first hour. Then the drift started:

On 4 November the market cap stood at $15.92M and the fully diluted value at $176.93M. Daily volume of $43.27M ran at 272% of market cap. Analyst Crypto Patel read the earlier 334% ratio as Binance Alpha points farming rather than demand. CoinMarketCap's own analysis of the 19 October drop found no project-specific trigger, only profit-taking after a 181% week.

The holder picture explains the swings. GeckoTerminal counted 8,843 wallets in mid-October, and the top 10 held 98.86% of supply. Those wallets are unlabeled. Labels would show how much sits in vesting and treasury contracts, and nobody outside the team has published that map.

What users and analysts report

Feedback on NeoTrade is sparse and comes almost entirely from crypto social media. We found no app-store page, no Trustpilot profile and no independent test of agent results. What does exist splits into three threads.

The first is ease of use. Early testers on X and Binance Square describe natural-language strategy setup as easy to start with. None of those posts publish returns.

The second is the airdrop. The 6% allocation was split across Binance Alpha points claims, a Gate launchpool of 2.8M DNA and NeoSoul's own checker, which only passed wallets that cleared Sybil screening. The check window closed on 23 October. On 20 October NeoSoul also sent a first batch of DNA to users of StandX, a platform that had scaled back operations and told users to withdraw. NeoSoul had promised that allocation on 15 October. It is a gesture, not a refund, but it was kept.

The third is the ticker. DNA is crowded. Older tokens use it, and a Solana pump.fun token trades under the NeoSoul name with no connection to the project. AI-generated "explainer" pages also describe NeoSoul as a music-royalty chain or a standalone layer 1, both wrong. The only official contract is 0xA991F61940095AEA0724ef54077223B048c5CF7b on BNB Chain.

For Canadian readers there is a venue question. OKX left Canada in 2023, and the CSA directs residents to registered crypto trading platforms. Check that list before using any exchange that carries DNA.

Prospects: what DNA demand depends on

NeoSoul's product and DNA's price move on separate tracks. The token captures value only if NeoTrade usage turns into DNA purchases, and that link is still a promise.

Four checkpoints decide how the project reads a year from now:

1. The KPI framework. Publication of measurable, outside-checkable targets for team unlocks.
2. DNA payments in NeoTrade. The switch from announcement to a live requirement, with usage data.
3. Exchange venues in NeoTrade. Support beyond prediction markets widens the user base the token depends on.
4. October 2027. Investor, treasury and advisor cliffs end, adding 12.0M DNA per month from those three pools alone.

The supply arithmetic is plain. Circulation is set to rise from 130M to 355M over the first year by the project's own schedule, while demand from product payments is zero today. If NeoTrade fees do not start buying DNA before the 2027 cliffs, holders could face steady sell pressure with no offsetting buyer.